Rhode Island Hospital and The Miriam Hospital — Providence, Rhode Island

Rhode Island Hospital and The Miriam Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Rhode Island Hospital and The Miriam Hospital has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell.

Sponsors: Brown University, Angela Taber MD, howard safran.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Providence

Browse all research sites in Rhode Island · View every site in Providence

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital and The Miriam Hospital?

Rhode Island Hospital and The Miriam Hospital has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital and The Miriam Hospital conducted?

Rhode Island Hospital and The Miriam Hospital has 6 clinical trials on record, with 1 currently active. Their work covers Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell.

Is Rhode Island Hospital and The Miriam Hospital accredited by Crixeo Clinical Trials?

Rhode Island Hospital and The Miriam Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital and The Miriam Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.